The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA's science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the state of regulatory science and to consider approaches for enhancing it.
Table of Contents |
skim chapter | |
|---|---|---|
| Front Matter | i-xvi | |
| 1 Introduction | 1-4 | |
| 2 Defining Regulatory Science | 5-12 | |
| 3 The Urgent Need for Regulatory Science | 13-22 | |
| 4 Barriers to Enhanced Regulatory Science | 23-30 | |
| 5 Potential Models for Building a Regulatory Science Infrastructure | 31-38 | |
| 6 Challenges in Engaging the Public Policy Community | 39-44 | |
| 7 Envisioning Successful Regulatory Science at FDA | 45-48 | |
| 8 Considering Next Steps | 49-52 | |
| References | 53-56 | |
| Appendix A: Agenda | 57-60 | |
| Appendix B: Participant Biographies | 61-78 | |
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
E-mail: info@copyright.com
Web: https://www.copyright.com
Loading stats for Building a National Framework for the Establishment of Regulatory Science for Drug Development: Workshop Summary...
Finding similar items...
